share_log

Denali Therapeutics Is Maintained at Overweight by JP Morgan

Denali Therapeutics Is Maintained at Overweight by JP Morgan

JP摩根維持對Denali Therapeutics的股票評級爲“增持”
道瓊斯 ·  07/10 12:36

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論